These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8390656)

  • 1. [TNM and grading as prognostic factors in breast cancer].
    Ibáñez T; Bilbao J; Toledo JD
    Pathologe; 1993 May; 14(3):144-9. PubMed ID: 8390656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
    Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
    Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Micrometastases in axillary lymph nodes in breast cancer].
    Ronay G; Tomesch A; Tulusan AH
    Gynakol Rundsch; 1989; 29 Suppl 2():234-6. PubMed ID: 2558989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic factors in lymph node negative breast cancer patients].
    Brockmann B; Wildner GP
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):413-8. PubMed ID: 1615724
    [No Abstract]   [Full Text] [Related]  

  • 5. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bilateral primary breast cancer. An analysis of 64 cases].
    Xue ZQ
    Zhonghua Wai Ke Za Zhi; 1992 May; 30(5):284-6, 317. PubMed ID: 1337736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast cancer treatment].
    Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
    Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the breast in men.
    Lefor AT; Numann PJ
    N Y State J Med; 1988 Jun; 88(6):293-6. PubMed ID: 2841627
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on Rahusen et al.
    Dupont EL; Cox CE; Riker A; Furman B
    Breast J; 2004; 10(3):267; author reply 268-9. PubMed ID: 15125762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathology and classification of malignant breast tumors].
    Bässler R
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):973-80. PubMed ID: 1663676
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of the in situ component in 389 infiltrating ductal breast carcinomas.
    Carabias-Meseguer P; Zapardiel I; Cusidó-Gimferrer M; Godoy-Tundidor S; Tresserra-Casas F; Rodriguez-García I; Fábregas-Xauradó R; Xercavins-Montosa J
    Breast Cancer; 2013 Jul; 20(3):213-7. PubMed ID: 22271067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage breast cancer rates rise sharply as invasive breast cancer levels off.
    Oncology (Williston Park); 2005 Aug; 19(9):1176. PubMed ID: 16404785
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
    Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
    Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratios of involved nodes in early breast cancer.
    Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M
    Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
    Ronay G; Zimmermann HD; Tulusan AH
    Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.